Supplementary Table S1: RT-PCR primers sequence

MT3-F acctcctgcaagaagagctg
MT3-R cagctgcacttctctgcttct
P21-F ccttccagctcctgtaacatact
P21-R aacgggaaccaggacacatg
PUMA-F gacgacctcaacgcacagta
PUMA-R gtaagggcaggagtcccat
BAX-F ccttttctacctttgccagcaaac
BAX-R gaggccgtcccaaccac
Beta Actin-F cctggcacccagcacaat Beta Actin-R gccgatccacacggagtact Summary of the volume (V in mm^3, X±S) of tumor for each treatment group and the number (n) of mice that survived and were scanned by MRI in each of the seven weeks follow up (FU). In addition to significant high death rate and volume of tumor for the no treatment and DMSO+zinc treatment, a significant pvalue <0.05 (*) was detected between volume of TMZ and the combination treatment at FU 5. If no mice survived in any follow up the volume is indicated as non applicable (NA).
